Abstract
In the recent years, natural products have emerged as modulators of many cellular responses with potential applications as therapeutic drugs in many disorders. Among them, capsaicin, the pungent principle of chili peppers, has received an increasing attention for its strong chemo-preventive and chemotherapeutic ability in recent few years. In this chapter some of the molecular and cellular events initiated by treatment of prostate cancer cells with capsaicin are addressed and the potential role of capsaicin signaling network as target for prostate cancer treatment is discussed. Capsaicin induces cell cycle arrest and apoptosis in the androgen-insensitive prostate cancer PC-3 and DU-145 cell lines. Among the pathways underlying the mechanisms of action of capsaicin, ROS generation and ceramide accumulation seem to be the most relevant. In prostate PC-3 cells, capsaicin also induces endoplasmic reticulum stress and caspase-3 activation. Moreover, capsaicin exhibits anti-tumor growth activity in prostate tumors induced in mice. The data suggest that capsaicin holds promise as a treatment option for prostate cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andela VB, Gordon AH, Zotalis G et al (2003) Nfkappab: a pivotal transcription factor in prostate cancer metastasis to bone. Clin Orthop Relat Res 415 Suppl:S75–85
Athanasiou A, Smith PA, Vakilpour S et al (2007) Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death. Biochem Biophys Res Commun 354(1):50–55
Bartke N, Hannun YA (2009) Bioactive sphingolipids: metabolism and function. J Lipid Res 50(Suppl):S91–96
Bartoletti R, Gavazzi A, Cai T et al (2009) Prostate growth and prevalence of prostate diseases in early onset spinal cord injuries. Eur Urol 56(1):142–148
Bidaux G, Roudbaraki M, Merle C et al (2005) Evidence for specific trpm8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement. Endocr Relat Cancer 12(2):367–382
Bieberich E (2004) Integration of glycosphingolipid metabolism and cell-fate decisions in cancer and stem cells: review and hypothesis. Glycoconj J 21(6):315–327
Bohlen CJ, Priel A, Zhou S, King D, Siemens J, Julius D (2010) A bivalent tarantula toxin activates the capsaicin receptor, trpv1, by targeting the outer pore domain. Cell 141(5):834–845
Brooks DD, Wolf A, Smith RA, Dash C, Guessous I (2010) Prostate cancer screening 2010: updated recommendations from the american cancer society. J Natl Med Assoc 102(5):423–429
Caterina MJ, Julius D (2001) The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 24:487–517
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389(6653):816–824
Chow J, Norng M, Zhang J, Chai J (2007) Trpv6 mediates capsaicin-induced apoptosis in gastric cancer cells – mechanisms behind a possible new “Hot” cancer treatment. Biochim Biophys Acta 1773(4):565–576
Chuang YC, Yoshimura N, Wu M et al (2007) Intraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects of botulinum toxin a. Eur Urol 51(4):1119–1127
Chuang YC, Yoshimura N, Huang CC, Wu M, Chiang PH, Chancellor MB (2008) Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. J Urol 180(2):742–748
Crane FL, Low H (2008) Reactive oxygen species generation at the plasma membrane for antibody control. Autoimmun Rev 7(7):518–522
Cui J, Bian JS, Kagan A, Mcdonald TV (2002) Cat1 contributes to the stores-operated calcium current in jurkat t-lymphocytes. J Biol Chem 277(49):47175–47183
Czifra G, Varga A, Nyeste K et al (2009) Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma. J Cancer Res Clin Oncol 135(4):507–514
De Luca T, Morre DM, Zhao H, Morre DJ (2005) Nad+/nadh and/or coq/coqh2 ratios from plasma membrane electron transport may determine ceramide and sphingosine-1-phosphate levels accompanying g1 arrest and apoptosis. Biofactors 25(1–4):43–60
Dinis P, Charrua A, Avelino A et al (2005) The distribution of sensory fibers immunoreactive for the trpv1 (capsaicin) receptor in the human prostate. Eur Urol 48(1):162–167
Fernandez-Ballester G, Ferrer-Montiel A (2008) Molecular modeling of the full-length human trpv1 channel in closed and desensitized states. J Membr Biol 223(3):161–172
Ferrer-Montiel A, Garcia-Martinez C, Morenilla-Palao C et al (2004) Molecular architecture of the vanilloid receptor. Insights for drug design. Eur J Biochem 271(10):1820–1826
Fixemer T, Wissenbach U, Flockerzi V, Bonkhoff H (2003) Expression of the ca2+-selective cation channel trpv6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene 22(49):7858–7861
Fizazi K, Sternberg CN, Fitzpatrick JM, Watson RW, Tabesh M (2010) Role of targeted therapy in the treatment of advanced prostate cancer. BJU Int 105(6):748–767
Garcia-Cao I, Duran A, Collado M et al (2005) Tumour-suppression activity of the proapoptotic regulator par4. EMBO Rep 6(6):577–583
Gratzke C, Weinhold P, Reich O et al (2010) Transient receptor potential a1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells. Eur Urol 57(5):902–910
Hail N Jr (2003) Mechanisms of vanilloid-induced apoptosis. Apoptosis 8(3):251–262
Henshall SM, Afar DE, Hiller J et al (2003) Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. Cancer Res 63(14):4196–4203
Horoszewicz JS, Leong SS, Kawinski E et al (1983) Lncap model of human prostatic carcinoma. Cancer Res 43(4):1809–1818
Iype PT, Iype LE, Verma M, Kaighn ME (1998) Establishment and characterization of immortalized human cell lines from prostatic carcinoma and benign prostatic hyperplasia. Int J Oncol 12(2):257–263
Jankovic B, Loblaw DA, Nam R (2010) Capsaicin may slow psa doubling time: case report and literature review. Can Urol Assoc J 4(1):E9–E11
Jiang Z, Gorenstein NM, Morre DM, Morre DJ (2008) Molecular cloning and characterization of a candidate human growth-related and time-keeping constitutive cell surface hydroquinone (nadh) oxidase. Biochemistry 47(52):14028–14038
Jordt SE, Tominaga M, Julius D (2000) Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc Natl Acad Sci USA 97(14):8134–8139
Jung J, Hwang SW, Kwak J et al (1999) Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci 19(2):529–538
Kuramori C, Azuma M, Kume K et al (2009) Capsaicin binds to prohibitin 2 and displaces it from the mitochondria to the nucleus. Biochem Biophys Res Commun 379(2):519–525
Lallet-Daher H, Roudbaraki M, Bavencoffe A et al (2009) Intermediate-conductance ca2+-activated k+ channels (ikca1) regulate human prostate cancer cell proliferation through a close control of calcium entry. Oncogene 28(15):1792–1806
Lehen’kyi V, Flourakis M, Skryma R, Prevarskaya N (2007) Trpv6 channel controls prostate cancer cell proliferation via ca(2+)/nfat-dependent pathways. Oncogene 26(52):7380–7385
Lishko PV, Procko E, Jin X, Phelps CB, Gaudet R (2007) The ankyrin repeats of trpv1 bind multiple ligands and modulate channel sensitivity. Neuron 54(6):905–918
Liu X, Cheng JC, Turner LS et al (2009) Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy. Expert Opin Ther Targets 13(12):1449–1458
Macho A, Calzado MA, Munoz-Blanco J et al (1999) Selective induction of apoptosis by capsaicin in transformed cells: the role of reactive oxygen species and calcium. Cell Death Differ 6(2):155–165
Macho A, Sancho R, Minassi A, Appendino G, Lawen A, Munoz E (2003) Involvement of reactive oxygen species in capsaicinoid-induced apoptosis in transformed cells. Free Radic Res 37(6):611–619
Malagarie-Cazenave S, Olea-Herrero N, Vara D, Diaz-Laviada I (2009) Capsaicin, a component of red peppers, induces expression of androgen receptor via pi3k and mapk pathways in prostate lncap cells. FEBS Lett 583(1):141–147
Messeguer A, Planells-Cases R, Ferrer-Montiel A (2006) Physiology and pharmacology of the vanilloid receptor. Curr Neuropharmacol 4(1):1–15
Monet M, Lehen’kyi V, Gackiere F et al (2010) Role of cationic channel trpv2 in promoting prostate cancer migration and progression to androgen resistance. Cancer Res 70(3):1225–1235
Montell C, Birnbaumer L, Flockerzi V (2002) The trp channels, a remarkably functional family. Cell 108(5):595–598
Mori A, Lehmann S, O’kelly J et al (2006) Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res 66(6):3222–3229
Morre DJ, Morre DM (2006) Aging-related cell surface ecto-nox protein, arnox, a preventive target to reduce atherogenic risk in the elderly. Rejuvenation Res 9(2):231–236
Morre DJ, Chueh PJ, Morre DM (1995) Capsaicin inhibits preferentially the nadh oxidase and growth of transformed cells in culture. Proc Natl Acad Sci USA 92(6):1831–1835
Morre DJ, Sun E, Geilen C et al (1996) Capsaicin inhibits plasma membrane nadh oxidase and growth of human and mouse melanoma lines. Eur J Cancer 32A(11):1995–2003
Morre DJ, Caldwell S, Mayorga A, Wu LY, Morre DM (1997) Nadh oxidase activity from sera altered by capsaicin is widely distributed among cancer patients. Arch Biochem Biophys 342(2):224–230
Morre DJ, Morre DM, Shelton TB (2010) Aging-related nicotinamide adenine dinucleotide oxidase response to dietary supplementation: the french paradox revisited. Rejuvenation Res 13(2–3):159–161
Ozbayraktar FB, Ulgen KO (2009) Molecular facets of sphingolipids: mediators of diseases. Biotechnol J 4(7):1028–1041
Palayoor ST, Youmell MY, Calderwood SK, Coleman CN, Price BD (1999) Constitutive activation of ikappab kinase alpha and nf-kappab in prostate cancer cells is inhibited by ibuprofen. Oncogene 18(51):7389–7394
Peng JB, Zhuang L, Berger UV et al (2001) Cat1 Expression correlates with tumor grade in prostate cancer. Biochem Biophys Res Commun 282(3):729–734
Phelps CB, Procko E, Lishko PV, Wang RR, Gaudet R (2007) Insights into the roles of conserved and divergent residues in the ankyrin repeats of trpv ion channels. Channels (Austin) 1(3):148–151
Prevarskaya N, Zhang L, Barritt G (2007) Trp channels in cancer. Biochim Biophys Acta 1772(8):937–946
Rho YW, Bae YS (2010) Capsaicin, a component of red peppers, stimulates protein kinase ckii activity. BMB Rep 43(5):325–329
Sanchez MG, Sanchez AM, Collado B et al (2005) Expression of the transient receptor potential vanilloid 1 (trpv1) in lncap and pc-3 prostate cancer cells and in human prostate tissue. Eur J Pharmacol 515(1–3):20–27
Sanchez AM, Sanchez MG, Malagarie-Cazenave S, Olea N, Diaz-Laviada I (2006) Induction of apoptosis in prostate tumor pc-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin. Apoptosis 11(1):89–99
Sanchez AM, Malagarie-Cazenave S, Olea N, Vara D, Chiloeches A, Diaz-Laviada I (2007) Apoptosis induced by capsaicin in prostate pc-3 cells involves ceramide accumulation, neutral sphingomyelinase, and jnk activation. Apoptosis 12(11):2013–2024
Sanchez AM, Martinez-Botas J, Malagarie-Cazenave S et al (2008) Induction of the endoplasmic reticulum stress protein gadd153/chop by capsaicin in prostate pc-3 cells: a microarray study. Biochem Biophys Res Commun 372(4):785–791
Sells SF, Wood DP Jr, Joshi-Barve SS et al (1994) Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ 5(4):457–466
Sells SF, Han S, Muthukkumar S et al (1997) Expression and function of the leucine zipper protein par-4 in apoptosis. Mol Cell Biol 17(7):3823–3832
Sikka SC, Huang L et al (2010) Novel role for the transient receptor potential channel trpm2 in prostate cancer cell proliferation. Prostate Cancer Prostatic Dis 13(2):195–201
Stavridi F, Karapanagiotou EM, Syrigos KN (2010) Targeted therapeutic approaches for hormone-refractory prostate cancer. Cancer Treat Rev 36(2):122–130
Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF (1978) Isolation of a human prostate carcinoma cell line (du 145). Int J Cancer 21(3):274–281
Szallasi A (2001) Vanilloid receptor ligands: hopes and realities for the future. Drugs Aging 18(8):561–573
Tsavaler L, Shapero MH, Morkowski S, Laus R (2001) Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res 61(9):3760–3769
Ursu D, Knopp K, Beattie RE, Liu B, Sher E (2010) Pungency of trpv1 agonists is directly correlated with kinetics of receptor activation and lipophilicity. Eur J Pharmacol 641(2–3):114–122
Van Der Aa F, Roskams T, Blyweert W, De Ridder D (2003) Interstitial cells in the human prostate: a new therapeutic target? Prostate 56(4):250–255
Vriens J, Appendino G, Nilius B (2009) Pharmacology of vanilloid transient receptor potential cation channels. Mol Pharmacol 75(6):1262–1279
Walpole CS, Wrigglesworth R, Bevan S et al (1993) Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 3. The hydrophobic side-chain “C-region”. J Med Chem 36(16):2381–2389
Walpole CS, Bevan S, Bloomfield G et al (1996) Similarities and differences in the structure-activity relationships of capsaicin and resiniferatoxin analogues. J Med Chem 39(15):2939–2952
Wang HP, Pu XY, Wang XH (2007) Distribution profiles of transient receptor potential melastatin-related and vanilloid-related channels in prostatic tissue in rat. Asian J Androl 9(5):634–640
Wang G, Yang ZQ, Zhang K (2010) Endoplasmic reticulum stress response in cancer: molecular mechanism and therapeutic potential. Am J Transl Res 2(1):65–74
Webber MM, Bello D, Quader S (1997) Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications part 2. Tumorigenic cell lines. Prostate 30(1):58–64
Wissenbach U, Niemeyer BA (2007) Trpv6. Handb Exp Pharmacol 179:221–234
Wissenbach U, Niemeyer BA, Fixemer T et al (2001) Expression of cat-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer. J Biol Chem 276(22):19461–19468
Wissenbach U, Niemeyer B, Himmerkus N, Fixemer T, Bonkhoff H, Flockerzi V (2004) Trpv6 And prostate cancer: cancer growth beyond the prostate correlates with increased trpv6 ca2+ channel expression. Biochem Biophys Res Commun 322(4):1359–1363
Yang ZH, Wang XH, Wang HP, Hu LQ (2009) Effects of trpm8 on the proliferation and motility of prostate cancer pc-3 cells. Asian J Androl 11(2):157–165
Zhang L, Barritt GJ (2004) Evidence that trpm8 is an androgen-dependent ca2+ channel required for the survival of prostate cancer cells. Cancer Res 64(22):8365–8373
Zhang L, Barritt GJ (2006) Trpm8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function? Endocr Relat Cancer 13(1):27–38
Acknowledgements
This work was supported by Ministerio de Ciencia e Innovación (grant SAF2008-03220), Comunidad de Madrid (grants CAM/UAH CCG08-UAH/BIO-3914 and CAM S-SAL-0261-2006) and Comunidad Castilla-LaMancha (Grant PII1/09-0165-0822).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Díaz-Laviada, I. (2013). Role of Capsaicin in Prostate Cancer. In: Srivastava, S. (eds) Role of Capsaicin in Oxidative Stress and Cancer. Diet and Cancer, vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6317-3_3
Download citation
DOI: https://doi.org/10.1007/978-94-007-6317-3_3
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6316-6
Online ISBN: 978-94-007-6317-3
eBook Packages: MedicineMedicine (R0)